Modify Centers for Medicare & Medicaid Services' Sepsis Core Measure (SEP-1) Now to Optimize Care for COVID-19
- PMID: 33587685
- PMCID: PMC7888050
- DOI: 10.7326/M20-8266
Modify Centers for Medicare & Medicaid Services' Sepsis Core Measure (SEP-1) Now to Optimize Care for COVID-19
Abstract
In the commentary, the authors urge the Centers for Medicare & Medicaid Services to remove lactate measurement from the national Severe Sepsis and Septic Shock Early Management Bundle (SEP-1) during the COVID-19 crisis.
Conflict of interest statement
References
-
- Jones AE , Shapiro NI , Trzeciak S , et al; Emergency Medicine Shock Research Network (EMShockNet) Investigators. Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial. JAMA. 2010;303:739-46. [PMID: ] doi:10.1001/jama.2010.158 - DOI - PMC - PubMed
-
- Hernández G , Ospina-Tascón GA , Damiani LP , et al; The ANDROMEDA SHOCK Investigators and the Latin America Intensive Care Network (LIVEN). Effect of a resuscitation strategy targeting peripheral perfusion status vs serum lactate levels on 28-day mortality among patients with septic shock: the ANDROMEDA-SHOCK randomized clinical trial. JAMA. 2019;321:654-664. [PMID: ] doi:10.1001/jama.2019.0071 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical